On October 7, 2022, the public-private collaboration projects from the National Program were granted to promote scientific-technical research and its transfer to the productive sector, within the framework of the Recovery, Transformation, and Resilience Plan. In this call, the Margarita Salas Center for Biological Research (CIB-CSIC) participates in five of the selected projects for whose execution it will receive funding of one million euros.
The objective of this call is to support experimental development projects in cooperation between companies and research organizations, in order to promote the development of new technologies, and the business application of new ideas and techniques, and to contribute to the creation of new products and services.
The five selected projects, led by researchers from the four departments of the CIB Margarita Salas, Microbial & Plant Biotechnology, Molecular Biomedicine, Cellular and Molecular Biology and Structural and Chemical Biology, have been:
- Preclinical development of monoclonal antibodies against IL13RA2 for cancer therapy, CANCERKINE (Ignacio Casal)
- Next-generation off-the-shelf CAR-NK cells derived from iPSCs for allogeneic immunotherapy of solid tumors, OSCAR-iNK (Daniel Bachiller).
- Obtaining healthy bread of high nutritional quality with vegetable matrices, microbial inocula, and innovative technological processes, NutriPanSalud (Gloria del Solar).
- Improvement of biosafety and animal welfare on farms and pork products through non-invasive laboratory diagnosis, environmental sensorization, and Big Data (María Montoya).